Natalie Boyle
VerifiedPennsylvania State University · Pathology
Active 2021–2026
About
Natalie Boyle is an Assistant Research Professor in the Department of Entomology at Pennsylvania State University. Her areas of expertise include honey bees, managed solitary bees, crop pollination, pollinator ecology, and integrated pest and pollinator management. She is involved in research related to pollinator health, behavior, and management strategies to enhance agricultural productivity and pollinator conservation. Her work focuses on understanding the nutritional, foraging, and nesting preferences of solitary bees, as well as the effects of environmental stressors such as heat exposure on bee sperm quality. Boyle's research also explores the role of wildflower plantings in promoting bee reproduction and the dynamics of pollination services in agricultural systems. She contributes to the Center for Pollinator Research and the Insect Biodiversity Center, advancing knowledge on pollinator biodiversity and sustainable management practices.
Research topics
- Biology
- Biochemistry
- Chemistry
- Virology
- Artificial Intelligence
- Computer Science
- Molecular biology
- Computational biology
- Medicine
- Cell biology
- Physics
- Computational chemistry
- Pharmacology
- Biophysics
Selected publications
Systemic rhythmicity of host and bacterial bile acid amidates in the mouse
Cell Systems · 2026-03-26 · 1 citations
articleOpen accessGlucuronidation metabolomic fingerprinting to map host-microbe metabolism
Nature Communications · 2026-05-20
articleOpen access1st authorCorrespondingGlucuronidation is an important detoxification pathway that operates in balance with gastrointestinal microbial β-glucuronidase (GUS) activity, which can regenerate bioactive metabolites from their glucuronidated forms. How this host-microbe interaction shapes the distribution and pool of glucuronidated metabolites (i.e., the glucuronidome) remains poorly understood. In this study, we employed pattern-filtering data science approaches in conjunction with untargeted LC-MS/MS metabolomics to map the glucuronidome in urine, serum, and colon/fecal samples from gnotobiotic and conventional mice, and in humans. We find that microbial colonization and GUS activity compress the colonic glucuronidome and expand urinary glucuronidome diversity, revealing a compartmental redistribution of glucuronidated metabolites. Reverse metabolomics of known glucuronidated chemicals and glucuronidation pattern filtering searches in public metabolomics datasets exposed the diversity of glucuronidated metabolites in human and mouse ecosystems. In summary, we present a glucuronidation fingerprint resource that provides broader access to and analysis of the glucuronidome. Together, this work establishes a scalable analytical framework and provides mechanistic insight into how microbial activity reshapes systemic glucuronidation, with implications for drug metabolism, diet-microbe interactions, and biomarker discovery.
Glucuronidation Metabolomic Fingerprinting to Map Host-Microbe Metabolism
Research Square · 2025-04-08 · 2 citations
preprintOpen accessGut microbiota impact on drug metabolism, bioavailability, and biotransformation
Elsevier eBooks · 2025-12-05
book-chapter1st authorCorrespondingElsevier eBooks · 2025-12-05
book-chapterSystemic Rhythmicity of Host and Bacterial Bile Acid Amidates Across the Mammalian Body
SSRN Electronic Journal · 2025-01-01
preprintOpen accessInactivation of HCoV-NL63 and SARS-CoV-2 in aqueous solution by 254 nm UV-C
Journal of Photochemistry and Photobiology B Biology · 2023-07-05 · 5 citations
articleToxicological Sciences · 2023-02-11 · 6 citations
articleOpen accessDespite progress describing the effects of persistent organic pollutants (POPs) on the central nervous system, the effect of POPs on enteric nervous system (ENS) function remains underexplored. We studied the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a POP, and a potent aryl hydrocarbon receptor (AHR) ligand, on the ENS and intestinal motility in mice. C57Bl/6J mice treated with TCDD (2.4 µg/kg body weight) for 8 weeks (once per week) exhibited significant delay in intestinal motility as shown by reduced stool frequency, prolonged intestinal transit time, and a persistence of dye in the jejunum compared to control mice with maximal dye retention in the ileum. TCDD significantly increased Cyp1a1 expression, an AHR target gene, and reduced the total number of neurons and affected nitrergic neurons in cells isolated from WT mice, but not Ahr-/- mice. In immortalized fetal enteric neuronal cells, TCDD-induced nuclear translocation of AHR as well as increased Cyp1a1 expression. AHR activation did not affect neuronal proliferation. However, AHR activation resulted in enteric neuronal toxicity, specifically, nitrergic neurons. Our results demonstrate that TCDD adversely affects nitrergic neurons and thereby contributes to delayed intestinal motility. These findings suggest that AHR signaling in the ENS may play a role in modulating TCDD-induced gastrointestinal pathophysiology.
Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection
Angewandte Chemie · 2021-03-08 · 30 citations
articleOpen accessAbstract The receptor‐binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 spike (S) protein plays a central role in mediating the first step of virus infection to cause disease: virus binding to angiotensin‐converting enzyme 2 (ACE2) receptors on human host cells. Therefore, S/RBD is an ideal target for blocking and neutralization therapies to prevent and treat coronavirus disease 2019 (COVID‐19). Using a target‐based selection approach, we developed oligonucleotide aptamers containing a conserved sequence motif that specifically targets S/RBD. Synthetic aptamers had high binding affinity for S/RBD‐coated virus mimics ( K D ≈7 nM) and also blocked interaction of S/RBD with ACE2 receptors (IC 50 ≈5 nM). Importantly, aptamers were able to neutralize S protein‐expressing viral particles and prevent host cell infection, suggesting a promising COVID‐19 therapy strategy.
bioRxiv (Cold Spring Harbor Laboratory) · 2021-03-25 · 5 citations
preprintOpen accessABSTRACT The association of the receptor binding domain (RBD) of SARS-CoV-2 viral spike with human angiotensin converting enzyme (hACE2) represents the first required step for viral entry. Amino acid changes in the RBD have been implicated with increased infectivity and potential for immune evasion. Reliably predicting the effect of amino acid changes in the ability of the RBD to interact more strongly with the hACE2 receptor can help assess the public health implications and the potential for spillover and adaptation into other animals. Here, we introduce a two-step framework that first relies on 48 independent 4-ns molecular dynamics (MD) trajectories of RBD-hACE2 variants to collect binding energy terms decomposed into Coulombic, covalent, van der Waals, lipophilic, generalized Born electrostatic solvation, hydrogen-bonding, π-π packing and self-contact correction terms. The second step implements a neural network to classify and quantitatively predict binding affinity using the decomposed energy terms as descriptors. The computational base achieves an accuracy of 82.2% in terms of correctly classifying single amino-acid substitution variants of the RBD as worsening or improving binding affinity for hACE2 and a correlation coefficient r of 0.69 between predicted and experimentally calculated binding affinities. Both metrics are calculated using a 5-fold cross validation test. Our method thus sets up a framework for effectively screening binding affinity change with unknown single and multiple amino-acid changes. This can be a very valuable tool to predict host adaptation and zoonotic spillover of current and future SARS-CoV-2 variants.
Frequent coauthors
- 8 shared
Suresh V. Kuchipudi
University of Pittsburgh
- 6 shared
Victoria S. Cavener
Pennsylvania State University
- 4 shared
Ruth H. Nissly
Pennsylvania State University
- 4 shared
Meera Surendran Nair
- 3 shared
Edurne Rujas
Biofisika
- 3 shared
Abhinay Gontu
Pennsylvania State University
- 2 shared
Xinping Fu
- 2 shared
Costas D. Maranas
Pennsylvania State University
Labs
Education
Doctorate of Philosophy , Integrated and Biomedical Physiology
The Pennsylvania State University
- 2019
Master of Public Health
New York Medical College
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Natalie Boyle
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup